Monoclonal antibodies were once the star of COVID-19 outpatient treatments. Since they first became available in 2020 — even before the first vaccines — more than 3.5 million infusions of the ...

Reported COVID-19 cases and deaths in many low- and middle-income countries (LMICs) have been fewer than initially anticipated. However, even relatively small surges in COVID-19 infections in an LMIC ...

In the ongoing battle against COVID-19, the United States has leaned heavily on vaccines as its primary weapon. While vaccination has been a cornerstone of the country’s public health strategy, it's ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...

"Without it, I don't know how much worse I would have been," one patient said. Susan Eisen assumed her sore throat and headache would go away. Maybe she'd been working too hard, or not drinking enough ...

Monoclonal antibodies were once the star of COVID-19 outpatient treatments. Since they first became available in 2020 – even before the first vaccines – more than 3.5 million infusions of the ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Listen 3:32 Listen to the Story ...